Showing results (21-30 of 530) with videos related to
Sort By:
Pageof 53
The Journal of Headache and Pain|October 28, 2010
A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: relevance to indomethacin-sensitive headachesOliver Summ, Anna P Andreou, Simon Akerman, et al.Brain Research|November 12, 2002
The role of histamine in dural vessel dilationSimon Akerman, David J Williamson, Holger Kaube, et al.European Journal of Pharmacology|October 2, 2002
The effect of anti-migraine compounds on nitric oxide-induced dilation of dural meningeal vesselsSimon Akerman, David J Williamson, Holger Kaube, et al.Pain|March 30, 2016
Neuropeptide Y inhibits the trigeminovascular pathway through NPY Y1 receptor: implications for migraineMargarida-Martins Oliveira, Simon Akerman, Isaura Tavares, et al.Brain Research|June 15, 2004
GABAA receptor modulation of trigeminovascular nociceptive neurotransmission by midazolam is antagonized by flumazenilRobin James Storer, Simon Akerman, Kevin G Shields, et al.Headache|September 2, 2009
Oxygen inhibits neuronal activation in the trigeminocervical complex after stimulation of trigeminal autonomic reflex, but not during direct dural activation of trigeminal afferentsSimon Akerman, Philip R Holland, Michele P Lasalandra, et al.Pain|July 27, 2010
Inhibition of trigeminovascular dural nociceptive afferents by Ca(2+)-activated K(+) (MaxiK/BK(Ca)) channel openingSimon Akerman, Philip R Holland, Michele P Lasalandra, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 13, 2013
Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and "triptan" receptors: implications in migraineSimon Akerman, Philip R Holland, Michele P Lasalandra, et al.Annals of Clinical and Translational Neurology|September 9, 2016
Metabotropic glutamate receptor 5: a target for migraine therapyMaggie W Waung, Simon Akerman, Mark Wakefield, et al.Brain : a Journal of Neurology|October 16, 2012
A translational in vivo model of trigeminal autonomic cephalalgias: therapeutic characterizationSimon Akerman, Philip R Holland, Oliver Summ, et al.Pageof 53